Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Authors: Volker Kunzmann, Jens T Siveke, Hana Algül, Eray Goekkurt, Gabriele Siegler, Uwe Martens, Dirk Waldschmidt, Uwe Pelzer, Martin Fuchs, Frank Kullmann, Stefan Boeck, Thomas J Ettrich, Swantje Held, Ralph Keller, Ingo Klein, Christoph-Thomas Germer, Hubert Stein, Helmut Friess, Marcus Bahra, Ralf Jakobs, Ingo Hartlapp, Volker Heinemann, Elke Hennes, Udo Lindig, Thomas Geer, Michael Stahl, Metin Senkal, Thomas Südhoff, Matthias Egger, Christoph Kahl, Christina Große-Thie, Marcel Reiser, Stefan Mahlmann, Peter Fix, Holger Schulz, Georg Maschmeyer, Wolfgang Blau

Published: 2020-12-17

DOI: 10.1016/s2468-1253(20)30330-7

Source: Full article


Abstract

No abstract found.